Refusal To Review Moderna Flu Vaccine Application Came From FDA’s Prasad

Refusal To Review Moderna Flu Vaccine Application Came From FDA’s Prasad A team of scientists was set to review the company's flu vaccine for people 50 and older, but the director of the Center for Biologics Evaluation and Research quashed the application. Plus: The U.S. will participate in a Feb. 26 WHO meeting to discuss the composition of the 2026-27 flu vaccine. https://kffhealthnews.org/morning-breakout/refusal-to-review-moderna-flu-vaccine-application-came-from-fdas-prasad/